(R)-1-Pyrimidin-2-yl-pyrrolidin-3-ol
- $315 - $711.9
- Product name: (R)-1-Pyrimidin-2-yl-pyrrolidin-3-ol
- CAS: 181959-76-2
- MF: C8H11N3O
- MW: 165.19
- EINECS:
- MDL Number:
- Synonyms:(R)-1-Pyrimidin-2-yl-pyrrolidin-3-ol;(3R)-1-pyrimidin-2-ylpyrrolidin-3-ol;3-Pyrrolidinol, 1-(2-pyrimidinyl)-, (R)- (9CI)
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
Package
- 5MG
- 500MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0008130
- Product description(R)-1-PYRIMIDIN-2-YL-PYRROLIDIN-3-OL 95.00%
- Packaging500MG
- Price$711.9
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0008130
- Product description(R)-1-PYRIMIDIN-2-YL-PYRROLIDIN-3-OL 95.00%
- Packaging5MG
- Price$496.19
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM300766
- Product description(R)-1-(pyrimidin-2-yl)pyrrolidin-3-ol 95%
- Packaging500mg
- Price$315
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CCH0008130 | (R)-1-PYRIMIDIN-2-YL-PYRROLIDIN-3-OL 95.00% | 500MG | $711.9 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CCH0008130 | (R)-1-PYRIMIDIN-2-YL-PYRROLIDIN-3-OL 95.00% | 5MG | $496.19 | 2021-12-16 | Buy |
Chemenu | CM300766 | (R)-1-(pyrimidin-2-yl)pyrrolidin-3-ol 95% | 500mg | $315 | 2021-12-16 | Buy |
Properties
Boiling point :355.0±52.0 °C(Predicted)
Density :1.296±0.06 g/cm3(Predicted)
pka :14.43±0.20(Predicted)
Density :1.296±0.06 g/cm3(Predicted)
pka :14.43±0.20(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|